Atlanta-based Marcus Autism Center, a subsidiary of Children’s Healthcare of Atlanta, and Emory University School of Medicine were awarded up to $17.25 million from Aligning Research to Impact Autism.
The funding will allow the providers to join the Innovative Medicine and Precision Approaches to Clinical Trials (IMPACT) Network, according to a Sept. 8 news release from the center. The IMPACT Network will begin with a focus on genetic discovery for profound autism and related genetically based neurodevelopmental disorders. Marcus Autism Center is one of an initial 12 sites selected from the U.S. and Europe to join the network.
Ami Klin, PhD, principal investigator and director of Marcus Autism Center, is leading the research at the center. Researchers will study children with profound autism and genetically based neurodevelopmental disorders, with a focus on advanced experimental trials using precision medicine approaches such as gene therapy and direct brain stimulation.
Earlier this year, Marcus Autism Center received $21.9 million from The Marcus Foundation to conduct a study of behavior, brain and genomic biomarkers in children across the autism spectrum and associated genetic neurodevelopmental conditions. The two grants combined total nearly $40 million.
At the Becker's Fall Behavioral Health Summit, taking place November 4–5 in Chicago, behavioral health leaders and executives will explore strategies for expanding access to care, integrating services, addressing workforce challenges and leveraging innovation to improve outcomes across the behavioral health continuum. Apply for complimentary registration now.
